|1.||Mandal, Subhrangsu S: 4 articles (05/2011 - 05/2009)|
|2.||Ansari, Khairul I: 3 articles (01/2011 - 05/2009)|
|3.||Kasiri, Sahba: 3 articles (01/2011 - 05/2009)|
|4.||Grant, James D: 3 articles (01/2011 - 05/2009)|
|5.||De Monte, Celeste: 2 articles (02/2015 - 12/2013)|
|6.||Supuran, Claudiu T: 2 articles (02/2015 - 12/2013)|
|7.||Carradori, Simone: 2 articles (02/2015 - 12/2013)|
|8.||Yazdanparast, Razieh: 2 articles (01/2014 - 12/2010)|
|9.||Törnroos, Karl W: 2 articles (03/2009 - 02/2006)|
|10.||Meermann, Christian: 2 articles (03/2009 - 02/2006)|
01/01/2015 - "Fe(Salen) is an anti-cancer compound with magnetic property, which is suitable for drug delivery and imaging. "
10/01/2014 - "This is the first report demonstrating that Fe(salen)Cl can specifically target the tumor cells, leaving the primary cells least affected, indicating an excellent potential for this compound to emerge as a next-generation anti-tumor drug. "
10/01/2014 - "We also established that apoptosis in the Fe(salen)Cl-treated tumor cells is mediated through caspase-dependent pathway. "
10/01/2014 - "Fe(salen)Cl induces cell death specifically in tumor cells and not in primary cells. "
10/01/2014 - "Induction of apoptosis by Fe(salen)Cl through caspase-dependent pathway specifically in tumor cells."
|2.||Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
|4.||Breast Neoplasms (Breast Cancer)
05/01/2009 - "Our results demonstrated that Mn(III)-salen derivatives affect cell viability, induce nuclear condensation and fragmentation in breast cancer cells (MCF7). "
01/01/2011 - "Their results demonstrated that Fe(III)-salen and salphen complexes affect cell viability and induce nuclear fragmentation and apoptosis in breast cancer (MCF7) cells. "
10/28/2009 - "Importantly, several Mn(III)-salen and -salphen complexes showed about 2-3 fold selectivity toward cancer cells such as MCF7 (breast cancer), and CCL228 (colon cancer) over a normal non-malignant cell MCF10 (breast epithelial cells) indicating their potential application towards novel anti-tumour therapy."
|5.||Melanoma (Melanoma, Malignant)
01/01/2015 - "In mouse leg tumor and tail melanoma models, Fe(Salen) delivery with magnet caused a robust decrease in tumor size, and the accumulation of Fe(Salen) was visualized by magnetic resonance imaging. "
04/01/2012 - "The 1d-polymeric iron(III) complexes [Fe(salen)(μ-L)](n) (1-6), involving a deprotonated form of the N-donor heterocyclic compounds (L) imidazole (complex 1), 1,2,4-triazole (2), benztriazole (3), 5-methyltetrazole (4), 5-aminotetrazole (5) and 5-phenyltetrazole (6), were studied for their in vitro cytotoxic activity against human cancer cell lines including lung carcinoma (A549), cervix epithelial carcinoma (HeLa), osteosarcoma (HOS), malignant melanoma (G361), breast adenocarcinoma (MCF7), ovarian carcinoma (A2780) and cisplatin-resistant ovarian carcinoma (A2780cis). "
|4.||disalicylaldehyde ethylenediamine (salen)
|8.||Cytochromes c (Cytochrome c)
|9.||Phenol (Carbolic Acid)